Cosentyx and Visual field defect - a phase IV clinical study of FDA data

Summary:

Visual field defect is reported as a side effect among people who take Cosentyx (secukinumab), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Sitagliptin, and have Psoriasis.

The phase IV clinical study analyzes which people have Visual field defect when taking Cosentyx. It is created by eHealthMe based on reports of 187,010 people who have side effects when taking Cosentyx from the FDA, and is updated regularly.

What is Cosentyx?

Cosentyx has active ingredients of secukinumab. It is often used in psoriatic arthritis. eHealthMe is studying from 187,247 Cosentyx users. Check the latest studies of Cosentyx.

What is Visual field defect?

Visual field defect is found to be associated with 766 drugs and 1,038 conditions by eHealthMe. Check the latest studies of Visual field defect.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

187,010 people reported to have side effects when taking Cosentyx.
Among them, 37 people (0.02%) have Visual field defect.

Could Cosentyx cause Visual field defect?

Among these 37 people:

How long have people been on Cosentyx when they have Visual field defect? *

What is the gender of people who have Visual field defect when taking Cosentyx? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Visual field defect when taking Cosentyx? *

What are other drugs people take besides Cosentyx? *

What are other side effects people have besides Visual field defect? *

Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 14 people, 37.84%
Iiird Nerve Paralysis (totally closed eyelid and a down and out deviation of the eye): 12 people, 32.43%
High Blood Cholesterol: 12 people, 32.43%
Glycosylated Haemoglobin Increased: 12 people, 32.43%
Oedema Mucosal (swelling of mucous membrane): 12 people, 32.43%
Eye Movement Disorder: 12 people, 32.43%
Diplopia (double vision): 12 people, 32.43%
Osgood-Schlatter Disease (an overuse injury that occurs in the knee area of growing adolescents. it is caused by inflammation of the tendon below the kneecap): 12 people, 32.43%
Thyroid Mass: 12 people, 32.43%
Urinary Tract Infection: 12 people, 32.43%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 20 people, 54.05%
Type 2 Diabetes: 12 people, 32.43%
High Blood Pressure: 9 people, 24.32%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 21.62%

* Approximation only. Some reports may have incomplete information.

Do you take Cosentyx and have Visual field defect?

- Check whether Visual field defect is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cosentyx:

Cosentyx (187,247 reports)

Browse all side effects of Cosentyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual field defect:

Visual field defect (766 drugs)

Browse all the conditions that are associated with Visual field defect:

Visual field defect (1,038 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on secukinumab (the active ingredients of Cosentyx) and Cosentyx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.